Paper11114375
Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.
Kumanogoh A and 15 others. Immunity, 2000. Cited by 299 papers, by iCite.
Cite this record
ConductScience Library. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Papers, record 11114375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11114375
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Antigens, Differentiation, B-Lymphocyte | Major topic |
| B-Lymphocytes | Major topic |
| Membrane Glycoproteins | Major topic |
| Receptors, Immunologic | Major topic |
| Semaphorins | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| CHO Cells | |
| Cricetinae |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA68675 | NCI NIH HHS | United States | R01CA068675 | PubMed and NIH |
Source NIH RePORTER
Cited by141
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 299 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42774833 | Transmembrane lectins in cancer immunity: emerging drivers of myeloid-mediated immunosuppression. | Front Immunol | 2026 | https://conductscience.org/library/papers/42774833 | PubMed |
| 42524290 | Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing-remitting multiple sclerosis: a case-control study. | Front Neurol | 2026 | https://conductscience.org/library/papers/42524290 | PubMed |
| 42367882 | Sequential and coordinated control of human plasma cell differentiation by IRF4 and BLIMP1 utilizing a discriminating ISRE/EICE motif lexicon. | bioRxiv | 2026 | https://conductscience.org/library/papers/42367882 | PubMed |
| 42317326 | Cell-autonomous co-stimulatory function of membrane-bound CD100 promotes activation and differentiation of HBcAg-specific CD8+ T cells. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317326 | PubMed |
| 41998221 | Semaphorin 4D (CD100) expression as a predictor for the response to induction therapy in pediatric patients with B-acute lymphoblastic leukemia. | Eur J Pediatr | 2026 | https://conductscience.org/library/papers/41998221 | PubMed |
| 41664229 | Semaphorins: from CD8⁺ T cells to cancer immunotherapy. | Biomark Res | 2026 | https://conductscience.org/library/papers/41664229 | PubMed |
| 41540405 | Single-cell sequencing-based analysis of CD4 + T-cell and B-cell heterogeneity in patients with lupus nephritis. | BMC Med Genomics | 2026 | https://conductscience.org/library/papers/41540405 | PubMed |
| 40728959 | FCGR2A-131R Is Associated with Lupus Nephritis Rather than Non-Lupus Nephritis SLE in an Indigenous African Caribbean Population. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40728959 | PubMed |
| 40362578 | Research Advances in the Immunomodulatory Functions of CD100/SEMA4D and Their Roles in Viral Infectious Diseases. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362578 | PubMed |
| 39391510 | Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma. | Heliyon | 2024 | https://conductscience.org/library/papers/39391510 | PubMed |
| 39026665 | Soluble CD72, is a T-cell activator probably via binding to CD6 in homeostasis and autoimmunity. | Front Immunol | 2024 | https://conductscience.org/library/papers/39026665 | PubMed |
| 38396409 | Soluble Semaphorin 4D Serum Concentrations Are Elevated in Critically Ill Patients with Liver Cirrhosis and Correlate with Aminotransferases. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/38396409 | PubMed |
| 38261512 | Repopulated spinal cord microglia exhibit a unique transcriptome and contribute to pain resolution. | Cell Rep | 2024 | https://conductscience.org/library/papers/38261512 | PubMed |
| 38097864 | Sema4D as a biomarker for Predicting rheumatoid arthritis disease activity. | Clin Rheumatol | 2024 | https://conductscience.org/library/papers/38097864 | PubMed |
| 37794420 | Pre-pregnancy gene expression signatures are associated with subsequent improvement/worsening of rheumatoid arthritis during pregnancy. | Arthritis Res Ther | 2023 | https://conductscience.org/library/papers/37794420 | PubMed |
| 37645659 | Semaphorins in immune cell function, inflammatory and infectious diseases. | Curr Res Immunol | 2023 | https://conductscience.org/library/papers/37645659 | PubMed |
| 37605412 | New Promising Routes in Peptic Ulcers: Toll-like Receptors and Semaphorins. | Endocr Metab Immune Disord Drug Targets | 2024 | https://conductscience.org/library/papers/37605412 | PubMed |
| 37291626 | Pathophysiological functions of semaphorins in the sympathetic nervous system. | Inflamm Regen | 2023 | https://conductscience.org/library/papers/37291626 | PubMed |
| 36231105 | Axon Guidance Molecules and Pain. | Cells | 2022 | https://conductscience.org/library/papers/36231105 | PubMed |
| 35681499 | CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies. | Cells | 2022 | https://conductscience.org/library/papers/35681499 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD40 | 958 | PubTator's text mining | https://conductscience.org/library/genes/958 | NCBI Gene |
| CD72 | 971 | PubTator's text mining | https://conductscience.org/library/genes/971 | NCBI Gene |
| NR0B2 | 8431 | PubTator's text mining | https://conductscience.org/library/genes/8431 | NCBI Gene |
| PTPN6 | 5777 | PubTator's text mining | https://conductscience.org/library/genes/5777 | NCBI Gene |
| SEMA4D | 10507 | PubTator's text mining | https://conductscience.org/library/genes/10507 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11114375
GET https://conductscience.org/api/papers/v1/11114375/cited_by?page=2